Trial intelligence / Profile preview

Liposomal Bupivacaine FICB for Perioperative Sleep Quality in Elderly Hip Fracture Patients

NCT07892859Completed

Start
Jan 2026
Primary completion
Sep 2026
Countries
1
01

Overview

Randomised, double-blind trial of liposomal bupivacaine in intertrochanteric fracture, hip fracture, sleep disorder and 2 more (2 arms). Primary endpoint: Leeds Sleep Evaluation Questionnaire score. Started Jan 2026; status: completed.

02

Drugs

liposomal bupivacaine
03

Conditions

intertrochanteric fracturehip fracturesleep disorderpostoperative delirium (POD)anxiety disorder

Beyond the preview

Go deeper on NCT07892859.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07892859.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call